Medical network - July 25, recently, the food and drug administration announced Chinese medicine yinpian unqualified notice, anhui. The Chinese medicine yinpian co., LTD. Companies and 20 of 26 Chinese medicine yinpian unqualified batch production. According to the information of the food and drug administration, this year, 532 batches were not qualified for drug sampling, and 410 batches of Chinese medicines were approved, accounting for more than 77 percent.
Chinese medicine and traditional Chinese medicine are indeed frequent problems, and regulators have been making a big deal in this area since last year, people inside and outside the industry told the media. But an undeniable fact is that Chinese medicine yinpian is not accounted for "medicine of" index evaluation of drugs, can get faster sales growth, every Chinese traditional medicine enterprise of Chinese medicine yinpian the layout of the market.
▍ frequency on "HeiBang"
In the past month, the food and drug administration has released 106 batches of unqualified products, including traditional Chinese medicine tablets, medicines and pharmaceutical packaging materials, and 98 batches of Chinese medicine tablets, accounting for over 92 percent of the total.
On June 22, the food and drug administration announced that 60 batches of the 60 batches of zhejiang bei mother, including Beijing shitang (yichang) pharmaceutical co., LTD., hebei four ray pharmaceutical co., LTD., were unqualified. On July 6, again released including force pharmaceutical co., LTD., jilin province, anhui best wo tong Chinese medicine yinpian co., LTD., 10 9 batches manufactured by enterprises in the goose, don is unqualified, badge bozhou anhui Chinese medicine yinpian co., LTD., zhejiang production 1 batches of boat-fruited sterculia is unqualified, guangxi Zhang Yitang Chinese medicine yinpian co., LTD. Production of 2 batches unqualified astragalus.
On July 20, the food and drug administration issued another 26 batches of alum, involving 20 companies, including anhui hukun traditional Chinese medicine co., LTD., Beijing meikang tang medical technology co., LTD.
It is reported that all the unqualified Chinese medicines will be seized and seized control measures will be seized, the market will be recalled, and the enterprises involved will be investigated.
Reporters found according to the food administration of drug safety information, since this year, total was revealed in terms of drug sampling 532 batches of unqualified, Chinese medicine yinpian, a total of 410 batches, accounts for more than 77%, unqualified project including character, extract, total ash, acid insoluble ash content, moisture, sulphur dioxide, content determination, camphor, volatiles, etc.
Chinese medicine and traditional Chinese medicine are indeed frequent problems, and regulators have been making a big deal in this area since last year, people inside and outside the industry told the media.
However, in the enterprises that GMP certification is confiscated, Chinese medicine yinpian enterprises also appear.
On July 18, the food and drug administration of qinghai province issued the announcement of the GMP certificate for the recovery of drugs (no. 1 of 2017), and five pharmaceutical companies were received GMP, both of which were enterprises of traditional Chinese medicine. On July 14, the food and drug administration of zhejiang province issued a certificate to recover the GMP certificate of jiaxing dongfang pharmaceutical co., LTD. On July 7, guangxi food and drug administration issued a certificate to recover the GPM certificate of Chinese traditional Chinese medicine yinpian co., LTD. According to the report of the food and drug administration, 172 GMP certificates were recovered in 2016, of which 81 were involved in traditional Chinese medicine, accounting for 47.6 percent.
▍ sales
HeiBang, Chinese medicine yinpian quality rate but some in the industry think like Chinese medicine yinpian is traditional Chinese medicine (TCM) industry of the intermediate links, on the one hand, can be directly processed by upstream of traditional Chinese medicine, taking as an agent or directly take, on the other hand can be used as raw material processed into proprietary Chinese medicine, into the downstream sales terminal. Many listed pharmaceutical companies increase the layout of the market for traditional Chinese medicine, with the "bright spot" of the growth of traditional Chinese medicine and traditional Chinese medicine enterprises.
Promulgated by the ministry on April 20, 2016 pharmaceutical industry leading economic indicators completion, and medicine in 2016 industrial enterprises above designated size implementation main business income is 2.963586 trillion yuan, among them, the Chinese medicine drink film industry main business income is 195.636 billion yuan, increased by 12.66%, compared to the same in the pharmaceutical industry segment after medical instruments and equipment manufacturing (year-on-year increase of 13.25%).
According to the annual report of 2016, the main business includes kangmei pharmaceutical co., LTD., which includes traditional Chinese medicine. In 2016, the operating income of Chinese traditional Chinese medicine was 4.7 billion yuan, up 26.43% from 2015, accounting for 21.74% of the company's total revenue. Xiangxue pharmaceutical 2016 annual report, the Chinese medicine yinpian has been reported to the varieties of more than 800, 2016, Chinese medicine yinpian business to achieve business income is 613 million yuan, the year-on-year growth of 55.16% in 2015, accounting for 32.9% of the company's total revenue.
In addition, the revenue of Chinese traditional Chinese medicine in 2016 was 43.57 billion yuan, accounting for 66.7% of the company's operating revenue. In 2016, the revenue of China's traditional Chinese medicine products was 18.77 billion yuan, accounting for 48.54 percent of the company's operating revenue.
MaiSiKang lai Shi Lichen founder said to the reporter, Chinese medicine yinpian is not accounted for "medicine proportion index evaluation of drugs," sales can get fast growth, every Chinese traditional medicine enterprise of Chinese medicine yinpian the layout of the market.
In addition, the policy level will also effect of Chinese medicine yinpian, April 21, the state development planning commission, the ministry of finance jointly issued notice, a part of September 30, all the abolition of all public hospital drug addition (except traditional Chinese medicine yinpian). People in the industry believe that the treatment will increase the consumption of Chinese medicine tablets and the market size of the Chinese medicine beverage market will continue to expand.
Wide according to the analysis of the hang seng medical institutions in the implementation of the "zero bonus" policy, the profit dropped sharply, and Chinese medicine yinpian, as this exception, will become an important focus of medical institutions to reduce the loss of, will increase the usage of Chinese medicine yinpian, Chinese medicine yinpian market size by 2017, 233 billion yuan, 273.4 billion yuan in 2018. |
